Professional Documents
Culture Documents
Bisoprolol Fumarate Tablets USP
Bisoprolol Fumarate Tablets USP
Bisoprolol Fumarate Tablets USP
(EST)
Printed by: Nguyen Nhan Official Date: Official Prior to 2013 Document Type: USP @2021 USPC
1
al
in a current of cold air.
dilute with an equal volume of Diluent.
ASSAY Chromatographic system
• PROCEDURE (See Chromatography á621ñ, System Suitability.)
Diluent: Acetonitrile and water (7:13) Mode: LC
Mobile phase: A 1-L portion of Diluent. Add 5 mL of Detector: UV 227 nm
heptafluorobutyric acid, 5 mL of diethylamine, and 2.5 mL
of formic acid.
System suitability solution: 0.5 mg/mL of propranolol
ci Column: 4.6-mm × 33-mm; packing L7
Flow rate: 1 mL/min
Injection size: 50 µL
hydrochloride and 1 mg/mL of bisoprolol fumarate in System suitability
Diluent Sample: Standard solution
ffi
Standard solution: 1 mg/mL of USP Bisoprolol Fumarate RS Suitability requirements
in Diluent Relative standard deviation: NMT 2.0%
Sample solution: Transfer an equivalent of 25 mg of Analysis
bisoprolol fumarate, from powdered Tablets (NLT 20), to a Samples: Standard solution and Sample solution
25-mL volumetric flask. Add 10 mL of Diluent, and sonicate Tolerances: NLT 80% (Q) of the labeled amount of
for 10 min. Cool, dilute with Diluent to volume, and mix. (C18H31NO4)2 · C4H4O4 is dissolved.
O
Centrifuge for 20 min, and use the clear supernatant. Test 2: If the product complies with this test, the labeling
Chromatographic system indicates that it meets USP Dissolution Test 2.
(See Chromatography á621ñ, System Suitability.) Medium: 0.5 M sodium chloride; 900 mL
Mode: LC Apparatus 2: 75 rpm
Detector: UV 273 nm Time: 20 min
Column: 4.6-mm × 12.5-cm; packing L7 Analysis: Proceed as directed for Test 1 with the following
Flow rate: 1 mL/min modifications.
Injection size: 10 µL Diluent: Prepare a mixture of methanol, 0.1 N
System suitability hydrochloric acid, triethylamine, and phosphoric acid
Samples: System suitability solution and Standard solution (160: 35: 5: 2.5). The dimensions of the column are
Suitability requirements 4.6 mm × 25 cm.
Resolution: NLT 7.0 between bisoprolol and Tolerances: NLT 80% (Q) of the labeled amount of
propranolol, System suitability solution (C18H31NO4)2 · C4H4O4 is dissolved.
Tailing factor: NMT 2.0, Standard solution • UNIFORMITY OF DOSAGE UNITS á905ñ: Meet the
Relative standard deviation: NMT 2.0%, Standard requirements
solution
Analysis ADDITIONAL REQUIREMENTS
Samples: Standard solution and Sample solution • PACKAGING AND STORAGE: Preserve in tight, light-resistant
Calculate the percentage of (C18H31NO4)2 · C4H4O4 in the containers, and store at controlled room temperature.
portion of Tablets taken: • LABELING: When more than one Dissolution test is given, the
labeling states the Dissolution test used only if Test 1 is
Result = (rU/rS) × (CS/CU) × 100 not used.
• USP REFERENCE STANDARDS á11ñ
rU = peak response from the Sample solution USP Bisoprolol Fumarate RS
rS = peak response from the Standard solution 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]
CS = concentration of USP Bisoprolol Fumarate RS in phenoxy]-3-[(1-methylethyl)amino]-, (±)-, (E)-
the Standard solution (mg/mL) 2-butenedioate (2:1) (salt).
CU = nominal concentration of bisoprolol fumarate in (C18H31NO4)2 · C4H4O4 766.96
the Sample solution (mg/mL)
https://online.uspnf.com/uspnf/document/1_GUID-0026274F-5226-4C1A-B9B8-FA18810AF594_1_en-US 1/1